137 related articles for article (PubMed ID: 8885619)
21. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
Kar BR; Job CK
Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
[TBL] [Abstract][Full Text] [Related]
22. Swollen Ears and Nose Bleeding Accompanied by Skin Papules.
Bauer B; Trautmann A
Pediatr Dermatol; 2015; 32(6):863-4. PubMed ID: 26584694
[No Abstract] [Full Text] [Related]
23. A case of lepromatous leprosy with multiple relapses.
Hulmani M; Marne RB; Dandakeri S
Lepr Rev; 2009 Jun; 80(2):210-4. PubMed ID: 19743626
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
[TBL] [Abstract][Full Text] [Related]
25. Recurrent erythema nodosum leprosum precipitated by antileprosy drugs.
Bhargava P; Kuldeep CM; Mathur NK
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):458-9. PubMed ID: 9030118
[No Abstract] [Full Text] [Related]
26. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
27. Guillain-Barré syndrome-like presentation in borderline leprosy with type-2 reaction.
Rai VM; Shenoi S; Rao SN
Dermatol Online J; 2006 Feb; 12(2):21. PubMed ID: 16638414
[TBL] [Abstract][Full Text] [Related]
28. Lack of response to WHO/MDT; a case report by Habtemariam and Xabier.
Pannikar VK
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):443-4. PubMed ID: 7963922
[No Abstract] [Full Text] [Related]
29. Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal.
Marlowe SN; Hawksworth RA; Butlin CR; Nicholls PG; Lockwood DN
Trans R Soc Trop Med Hyg; 2004 Oct; 98(10):602-9. PubMed ID: 15289097
[TBL] [Abstract][Full Text] [Related]
30. Autoaggressive lepromatous leprosy.
Dhar S; Kanwar AJ; Kaur S
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):467-8. PubMed ID: 8228449
[No Abstract] [Full Text] [Related]
31. Bullous necrotizing fixed drug eruption with hepatitis due to rifampicin.
Goel A; Balachandran C
Indian J Lepr; 2001; 73(2):159-62. PubMed ID: 11579651
[No Abstract] [Full Text] [Related]
32. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Ganapati R; Pai VV; Banerji U; Thomas J; Saha B
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):495-7. PubMed ID: 9465161
[No Abstract] [Full Text] [Related]
33. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
Pandhi D; Mehta S; Agrawal S; Singal A
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
[TBL] [Abstract][Full Text] [Related]
34. Do complications occur under multi-drug therapy?
Palande DD
Indian J Lepr; 1987; 59(4):369-72. PubMed ID: 3451922
[No Abstract] [Full Text] [Related]
35. Rifampicin-induced urticaria in leprosy.
Sharma VK; Kaur I; Vatve M; Kumar B
Lepr Rev; 1997 Dec; 68(4):331-2. PubMed ID: 9503869
[No Abstract] [Full Text] [Related]
36. Genital involvement and type I reaction in childhood leprosy.
Gupta R; Singal A; Pandhi D
Lepr Rev; 2005 Sep; 76(3):253-7. PubMed ID: 16248212
[TBL] [Abstract][Full Text] [Related]
37. Hansen's disease mimicking palmoplantar keratoderma.
Agrawal US; Saxena A; Meena RS; Saini M; Saxena V
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):210-2. PubMed ID: 12483971
[No Abstract] [Full Text] [Related]
38. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
39. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
[TBL] [Abstract][Full Text] [Related]
40. High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Ji B; Jamet P; Sow S; Perani EG; Traore I; Grosset JH
Antimicrob Agents Chemother; 1997 Sep; 41(9):1953-6. PubMed ID: 9303392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
